Now I have all the calibration data I need. Let me write the final consolidated review.

## Summary

This paper proposes a conformal prediction method for constructing lower prediction bounds (LPBs) for counterfactual survival times under general right-censored data. The core idea is to reweight the distribution of observed (treated, uncensored) samples to match the target counterfactual distribution via estimated density ratios, then apply weighted conformal prediction. The authors provide a finite-sample bound that quantifies how weight estimation error affects coverage (Theorem 4.1) and an asymptotic doubly-robust guarantee (Theorem 4.2). Experiments on synthetic data and an in-house NSCLC dataset (541 patients) are presented.

## Strengths

- **Well-motivated problem.** The paper correctly identifies a genuine gap: existing conformal methods for survival counterfactuals (Candès et al. 2023; Gui et al. 2024; Davidov et al. 2025) provide PAC-type guarantees or handle only Type-I censoring, whereas the proposed method targets marginal coverage under general right-censoring. Extending weighted conformal prediction to this setting is a useful direction.

- **Theorem 4.1 provides an honest bound.** The bound Coverage ≥ 1 − α − ½ E[|ω̂ − ω|] cleanly quantifies how weight estimation quality affects coverage. This follows cleanly from weighted conformal theory and is a meaningful theoretical result.

- **Doubly robustness claim (Theorem 4.2).** If correct, this is a genuine theoretical addition: asymptotic coverage holds if either the weight function or the quantile regression is consistently estimated. This goes beyond what prior survival conformal methods offer and reduces sensitivity to single-model misspecification.

- **Real clinical data.** The in-house NSCLC dataset (541 patients, 124 features, four treatment regimens) is a genuine empirical contribution that distinguishes this work from purely synthetic evaluations.

## Weaknesses

### Major

- **"Exact" guarantee framing is overstated.** The paper repeatedly claims "exact miscoverage guarantee" (abstract: "exact miscoverage guarantee," line 9; introduction: "exact marginally valid LPB," line 28; contributions: "distribution-free exact guarantee," line 33). However, Theorem 4.1 shows Coverage ≥ 1 − α − ½ E[|ω̂ − ω|] — a bound that degrades linearly with weight estimation error. In finite samples with estimated ω̂, coverage can fall below 1−α. The guarantee is exact only in the limit where ω̂ → ω. PAC methods criticized in the paper provide guarantees of the form "with probability ≥ 1−δ over the calibration data, coverage ≥ 1−α"; the proposed method provides "expected coverage ≥ 1−α − error(ω̂)." These are different relaxations of exact coverage, not a strict improvement over PAC. The framing should be calibrated to accurately reflect what is proved.

- **Equation (1) derivation is not self-consistent in the main text.** The chain from lines 127–138 claims step (ii) follows from the "tower property," but the factor 1/p(e=1|x,W=w) is not justified by that property. Step (iii) states an inequality (≤) whose direction — since ℙ(T ≤ ... | X,W) ≥ ℙ(T ≤ ..., e=1 | X,W) by set inclusion — should be ≥ when multiplied by the positive factor 1/p(e=1|...). The paper states (iii) is derived in Lemma A.1 in the appendix, so the full argument may resolve this. However, the main text as presented does not constitute a correct derivation on its own. Given this is the core theoretical connection, the main-text exposition must be made correct and self-contained.

- **No baseline comparison on real clinical data.** Figure 4 shows only the proposed method's results on the NSCLC dataset. The baselines (Naive, Focus, Fused) that were compared on synthetic data are entirely absent from the real-data evaluation. Appendix E.6 is referenced for baseline results but only in simulation settings. Without baselines, the real-data results provide no evidence that the proposed method is preferable to existing alternatives — they only demonstrate that the method produces LPBs consistent with clinical knowledge, which is a sanity check, not evidence of superiority.

### Minor

- **LPB optimization may affect coverage guarantee.** The paper selects τ per test point to maximize the LPB (lines 162–166). The coverage guarantee is stated as holding for any τ ∈ (0,1), but τ*(x) is chosen as a function of both the calibration data (through c(τ)(x)) and the test point. The standard conformal argument for "any τ" assumes τ is fixed before seeing calibration data; whether the guarantee survives data-dependent selection of τ is not analyzed. This is a known concern in conformal prediction and merits discussion or analysis.

- **The ignorability assumption (Assumption 3.1) is very strong.** It requires {T(1), T(0)} ⟂⟂ (W, C) | X, combining standard treatment ignorability with the requirement that *both* potential outcomes are independent of the censoring time. For a patient receiving treatment w=0, this requires their censoring time to be independent of what their survival would have been under treatment w=1 — stronger than the standard non-informative censoring assumption (T ⟂⟂ C | X, W). The paper acknowledges this briefly in the Discussion (line 288) but does not probe how violations would affect the method.

- **Calibration set discards most data in practice.** Algorithm 1 restricts calibration to (W_i = w, e_i = 1) — uncensored treated observations. In high-censoring or imbalanced-treatment scenarios, the effective calibration size shrinks substantially. The paper's experiments use moderate censoring rates, so this may not affect reported results, but the practical limitation for high-censoring settings is not quantified.

### Trivial

None.

## Nice-to-Haves

- Report effective calibration set sizes (number of uncensored treated observations) across experimental settings, and the relationship to coverage variance.
- Report weight estimation accuracy (e.g., MAE of γ̂ vs true γ on synthetic data) to empirically ground the error term in Theorem 4.1.
- A table of censoring rate and treatment proportion per synthetic setting would improve readability.

## Removed Points

- **Weakness about Theorem 4.2 conditions being "quite involved"**: complex technical conditions for asymptotic doubly-robust results are standard. Not a real weakness.
- **Criticism that PAC methods don't handle outliers**: This is what the paper claims to address; not a weakness of the paper.
- **"Outlier experiment needs weight estimation accuracy"**: Moved to Nice-to-Haves; it is a suggestion for strengthening, not a flaw.
- **"Comparison is post-hoc on real data"**: Merged into the baseline absence weakness above; the core issue is missing baselines, not the post-hoc nature of validation.
- **Section-by-section notes on Abstract/Introduction characterization of prior work**: Descriptive observations, not actionable weaknesses.

## Novel Insights

None beyond the paper's own contributions.

## Suggestions

1. **Quality "exact" throughout.** Replace claims like "exact miscoverage guarantee" with precise language such as "asymptotically exact marginal coverage guarantee with a finite-sample bound that depends on weight estimation quality."
2. **Fix equation (1).** Provide a corrected, self-contained derivation in the main text, or clearly reference the appendix and explain the key steps correctly in the main text.
3. **Add baselines to real-data experiment.** Run the same baselines (Naive, Focus, Fused) on the NSCLC dataset and report coverage and LPB comparisons.
4. **Address the τ-optimization issue.** Either prove that per-test-point τ selection preserves coverage (e.g., by a uniform bound or showing it is equivalent to a fixed τ), or provide an empirical check on synthetic data comparing oracle-τ vs. optimized-τ coverage.
5. **Discuss practical limitations more quantitatively.** Report effective calibration sizes and discuss when the method would break down (high censoring, severe imbalance).

---

**Calibration Anchors (Round 1):**

I first performed a bracketing pass querying six score bands (strong reject through strong accept) with topic-relevant queries. The results directly relevant to this paper's domain and methodology are:

| Band | Best Anchor | Avg Score | How It Compares |
|------|-------------|-----------|-----------------|
| Low (<1.5) | No relevant anchors | 1.00 | Irrelevant topics (GFlowNets, minimax paths) — no comparison needed |
| Reject (1.5–3.5) | "Regression Conformal Prediction under Bias" | 2.50 | Addresses CP under distribution shift; less ambitious than this paper |
| Borderline (3.5–5.5) | "Conformalized Survival Analysis for General Right-Censored Data" | 5.50 | Most directly related anchor — survival LPB for general right-censoring (non-counterfactual). This paper addresses a harder (counterfactual) problem and adds a doubly-robust result, but suffers from less clear derivation and overstated framing. |
| Borderline (3.5–5.5) | "Conformal prediction for causal effects of continuous treatments" | 5.50 | Uses weighted CP for causal effects with finite-sample guarantees. Comparable methodology, similar weaknesses (limited evaluation, under-coverage). |
| Weak accept (5.5–7.5) | "Conditional Testing based on Localized Conformal p-values" | 7.00 | Stronger conformal paper with cleaner theory, more comprehensive experiments. This paper is not at this level. |

**Initial bracket:** 4.0–6.0

**Narrowing pass (4.5–6.5):** Two directly relevant anchors (survival LPB at 5.50, continuous-treatment causal CP at 5.50) confirm the neighborhood. The present paper's derivation issues and framing problems lower it relative to these anchors, while its doubly-robust result and real clinical data partially compensate.

**Final bracket:** 5.0

MY FINAL SCORE: <score>5.0</score>
MY FINAL DECISION: <decision>Reject</decision>